Clinical Trial Update: Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses the combination of a TNF inhibitor with pamidronate in ankylosing spondylitis to evaluate effects on radiographic progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Pamidronate (pamidronate disodium)
• TNF inhibitor (tumor necrosis factor inhibitor)

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Ankylosing Spondylitis | Phase 4 | Status: UNKNOWN